860781 | α-Rhamnosyl FP20
6-O-α-D-Rhamnopyranosyl-1ß,2N,3-tridodecanoyl-D-glucosamine-4-phosphate, sodium salt

α-Rhamnosyl FP20
6-O-α-D-Rhamnopyranosyl-1ß,2N,3-tridodecanoyl-D-glucosamine-4-phosphate, sodium salt
FP-20 offers another innovative approach to boosting vaccine efficacy by selectively stimulating Toll-like receptor 4 (TLR4) pathways. The simplicity of FP structures allows for scalable production of highly pure materials, ensuring a reliable and cost-effective supply for vaccine developers. Like VSA, FP adjuvants provide both humoral and cellular immune enhancements but achieve this through a targeted, mechanism-driven approach.
C48H89NNaO15P |
CAS Registry Number is a Registered Trademark of the American Chemical Society
J. Med. Chem. 2023, 66, 4, 3010–3029Publication Date:February 2, 2023https://doi.org/10.1021/acs.jmedchem.2c01998
ACS Omega 2023, 8, 39, 36412–36417Publication Date:September 18, 2023https://doi.org/10.1021/acsomega.3c05363
J. Med. Chem. 2021, 64, 16, 12261–12272Publication Date:August 12, 2021https://doi.org/10.1021/acs.jmedchem.1c00896